Pharmaceutical waste from a Danish hospital.

Overgaard LK, Johansen KB, Krumborg JR, Nielsen ML, Christensen MMH, Pedersen SA

Regulation of cancer cell lipid metabolism and oxidative phosphorylation by microenvironmental acidosis.

Rolver MG, Severin M, Pedersen SF

Enabling spaces for (varied) co-existence.

Pedersen S, Nielsen E

Whole-genome sequencing for antimicrobial surveillance: species-specific quality thresholds and data evaluation from the network of the European Union Reference Laboratory for Antimicrobial Resistance genomic proficiency tests of 2021 and 2022.

Sørensen LH, Pedersen SK, Jensen JD, Lacy-Roberts N, Andrea A, S M Brouwer M, Veldman KT, Lou Y, Hoffmann M, Hendriksen RS

Label-free 3D molecular imaging of living tissues using Raman spectral projection tomography.

Stepula E, Walther AR, Jensen M, Mehrotra DR, Yuan MH, Pedersen SV, Kumar V, Gentleman E, Albro MB, Hedegaard MAB, Bergholt MS

Effectiveness of eDNA for monitoring riverine macroinvertebrates.

Poyntz-Wright IP, Harrison XA, Pedersen S, Tyler CR

Efficacy and safety of once-weekly semaglutide 2¡4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial.

McGowan BM, Bruun JM, Capehorn M, Pedersen SD, Pietiläinen KH, Muniraju HAK, Quiroga M, Varbo A, Lau DCW, STEP 10 Study Group

The impact of alcohol consumption on implicit racial bias.

Creswell KG, Brown KW, Pedersen SL

Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.

Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, Lingvay I, Colhoun HM, Plutzky J, Kosiborod MN, Hovingh GK, Hardt-Lindberg S, Frenkel O, Weeke PE, Rasmussen S, Goudev A, Lang CC, Urina-Triana M, Pietilä M, Lincoff AM, SELECT Trial Investigators

Real-World Cardiotoxicity in Metastatic Melanoma Patients Treated with Encorafenib and Binimetinib.

Pedersen S, Nielsen MØ, Donia M, Svane IM, Zerahn B, Ellebaek E

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.

Evering TH, Moser C, Jilg N, Ritz J, Wohl DA, Li JZ, Margolis D, Javan AC, Eron JJ, Currier JS, Daar ES, Smith DM, Hughes MD, Chew KW, ACTIV-2/A5401 Study Team

Ex Situ Gaseous Reagent for Multicomponent Amine Bioconjugation.

Ding Y, Pedersen SS, Wang Y, Xiao H, Ball ZT

Highly Involved Parenting of Adolescents With ADHD: Examination of the Psychometric Properties of a Measure of "Helicopter Parenting".

Botkin TN, Wiggs K, Kipp HL, Lindstrom RA, Joseph HM, Kolko DJ, Pedersen SL, Molina BSG

Telemetric ICP monitoring in children: a national questionnaire-based study.

Pedersen SH, Henriksen KA, Gustafsen SD, Hansen TS, Guldager R, Juhler M

Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance.

Stigliani A, Ialchina R, Yao J, Czaplinska D, Dai Y, Andersen HB, Rennie S, Andersson R, Pedersen SF, Sandelin A